Karina Claus
Papers
1
Total Citations
2
H-Index
1
About
Karina Claus is a clinical researcher whose work centers on advancing stereotactic body radiotherapy (SBRT) for oligometastatic disease, with a particular focus on robotic delivery systems (rSBRT). Her most cited study, "Efficacy and Toxicity of Robotic Stereotactic Body Radiotherapy of Lung Metastases in Patients With Oligometastatic Disease" (2023), systematically investigates the factors influencing treatment success in lung metastases—a critical area where evidence remains limited. By analyzing patient outcomes, Claus provides essential data on both the therapeutic efficacy and toxicity profiles of rSBRT, helping to refine patient selection and optimize radiation protocols. Her work directly addresses the clinical challenge of balancing local tumor control with minimizing harm, offering practical insights for oncologists managing oligometastatic patients. While her citation count is still growing, Claus’s contributions are foundational for emerging standards in non-invasive metastasis-directed therapy. Her research underscores a commitment to precision oncology, bridging technological innovation with real-world patient care.
Research Focus
Key Achievements
Top Papers
- 1